CoChat
Sign Up
Cited by 337Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and LipoproteinsCholesterol and Lipid Metabolism

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Lipids, risk factors and ischaemic heart disease

Castelli, William P.·1996·Atherosclerosis
DOI 10.1016/0021-9150(96)05851-0
Open this paper in CoChat — free account

Abstract

Over 200 risk factors for cardiovascular disease (CVD) have now been identified. Among these, the three most important are (1) abnormal lipids, including the fact that there are more than 15 types of cholesterol-containing lipoproteins and four different types of triglyceride-rich particles, some of which are very atherogenic, (2) high blood pressure, and (3) cigarette smoking. In addition, many other factors including diabetes, haemostatic factors such as fibrinogen, factor VII, plasminogen activator inhibitors, and new factors such as apolipoprotein E4 and homocysteine, are known to increase the risk of developing clinical CVD. A low risk for CVD requires that these various factors are present in the circulation in the correct proportions. Two simple tests for determining plasma lipid levels can be used to identify those individuals with an atherogenic lipid profile and who are, therefore, at increased risk for CVD. Firstly, the ratio of total cholesterol to high density cholesterol (HDL cholesterol) should be determined, followed by measurement of plasma triglyceride concentrations. This will allow differentiation of whether the low density lipoproteins (LDL), HDL cholesterol or triglyceride-rich particles such as the small dense beta-very low density lipoproteins (VLDL) are the major cause for concern. Once identified, those individuals with a high lipid risk profile should be treated before, rather than after, experiencing coronary heart disease (CHD).

Overview

Integrity signals

Registry

Crossref · 10.1016/0021-9150(96)05851-0

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 48 references

Research works printed but not linked: 3

  1. Hokanson, 1993, Triglyceride is a risk factor of coronary disease in men and women. A meta-analysis of population based prospective studies, Circulation, 88, 1
  2. Assmann, 1991, Triglycerides and atherosclerosis: results from the Prospective Cardiovascular Munster Study, Atherosclerosis Rev, 22, 51
  3. Bostom A, Cupples LA, Jenner J, et al. Elevated plasma lipoprotein (a) detected by electrophoresis predicts the development of premature coronary heart disease in men. In press.

Cited by

Sorted by citations

Related

See all

Metadata

Authors
Castelli, W. P.
Corresponding author
Castelli, William P.
Venue
Atherosclerosis
Publisher
Elsevier BV
Published
1996-07
Volume
124
Pages
S1-S9
ISSN
0021-9150 (ISSN-L)
DOI
10.1016/0021-9150(96)05851-0
OpenAlex
W1984793434
Cited by
337
References
48
Citations by year
2026: 3 · 2025: 4 · 2024: 3 · 2023: 6 · 2022: 4 · 2021: 12 · 2020: 5 · 2019: 7 · 2018: 11 · 2017: 15 · 2016: 16 · 2015: 13 · 2014: 15 · 2013: 16 · 2012: 16
FWCI
2.83
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Atherosclerosis (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Keywords
cardiovascular risk factors, ischemic heart disease, dyslipidemia, triglyceride-rich lipoproteins, HDL cholesterol, LDL cholesterol, plasma triglycerides, hypertension, cigarette smoking, APOE ε4, homocysteine, fibrinogen, plasminogen activator inhibitor, factor VII, cardiovascular disease prevention
MeSH terms
Anticholesteremic Agents, Blood Pressure, Diet, Homocysteine, Humans, Hypertension, Lipids, Risk Factors, Smoking, Myocardial Ischemia, Plasminogen Activator Inhibitor 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review